Skip to main content
SpringerLink
Log in

Treatment of Breast Cancer in the 1990s

What Does the Future Hold?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bonadonna G. Conceptual and practical advances in the management of breast cancer. Journal of Clinical Oncology 7: 1380–1397, 1987

    Google Scholar 

  • Bonadonna G, Rossi A, Valagussa P. Adjuvant CMF chemotherapy in operable breast cancer ten years later. World Journal of Surgery 9: 707–713, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bronchud MH, Howell A, Crowther D, et al. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. British Journal of Cancer 60: 121–125, 1989

    Article  PubMed  CAS  Google Scholar 

  • Buckley MM-T, Goa KL. Tamoxifen: A reapprasial of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs 37: 451–490, 1989

    Article  PubMed  CAS  Google Scholar 

  • Carmo-Pereira J, Costa FO, Henrigues E, et al. Advanced breast carcinoma: a comaprison of two dose levels of adriamycin. Abstract. Proceedings of the American Society of Clinical Oncology 5: 56, 1986

    Google Scholar 

  • Coates A, Gebski V, Bishop JF, et al. Improving the quality of life during chemotherapy for advanced breast cancer: a comparison of intermittent and continuous treatment strategies. New England Journal of Medicine 317: 1490–1495, 1987

    Article  PubMed  CAS  Google Scholar 

  • Decker DA, Ahmann DL, Bisel HF, Edmonson JH, et al. Complete responders to chemotherapy in metastatic breast cancer. Journal of the American Medical Association 242: 2075–2079, 1979

    Article  PubMed  CAS  Google Scholar 

  • Dicke KA, Vellekoop L, Zander A, Jagganath S, Poytiron C, et al. Autologous transplantation in acute leukemia. Survey and Synthesis of Pathology Research 4: 84–96, 1985

    PubMed  CAS  Google Scholar 

  • Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi G, Horowitz LJ, et al. Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. Journal of Clinical Oncology 8: 1207–1216, 1990

    PubMed  CAS  Google Scholar 

  • Fisher B, Fisher ER. The barrier function of the lymph node to tumor cells and erythrocytes. II. Normal nodes. Cancer 20: 1907–1913, 1967

    Article  PubMed  CAS  Google Scholar 

  • Fisher B, Slack NH, Cooperating Investigators. Number of lymph nodes examined and the prognosis of breast cancer. Surgery Gynecology and Obstetrics 131: 79–88, 1970

    CAS  Google Scholar 

  • Hollingshead LM, Goa KL. Récombinant granulocyte colonystimulating factor (rG-CSF): a review of its pharmacological properties and prospective role in neutropenic conditions. Drugs 42: 300–330, 1991

    Article  PubMed  CAS  Google Scholar 

  • Hortobagyi GN, Frye D, Buzdar AU, et al. Complete remissions in metastatic breast cancer. Abstract. Proceedings of the American Society of Clinical Oncology 7: 37, 1988

    Google Scholar 

  • Hryniuk W, Levine MN. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. Journal of Clinical Oncology 4: 1162–1170, 1986

    PubMed  CAS  Google Scholar 

  • Jones RB, Holland JF, Bhardwaj S, et al.: A phase I–II study of intensive-dose adriamycin for advanced breast cancer. Journal of Clinical Oncology 5: 172–177, 1987a

    PubMed  CAS  Google Scholar 

  • Jones SE, Moon TE, Bonadonna G, et al. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. American Journal of Clinical Oncology 10: 387–395, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Norton L, Simon R. Tumor size, sensitivity to therapy, and the design of treatment schedules. Cancer Treatment Reports 61: 1307–1317, 1977

    PubMed  CAS  Google Scholar 

  • Peters WP, Davis R, Shpall EJ, Jones RB, et al. Adjuvant chemotherapy involving high-dose combination cyclophosphamide, cisplatin, and carmustine (CPA/cDDP/BCNU) and autologous bone marrow support (ABMS) for stage II/III breast cancer involving ten or more lymph nodes (CALGB 8782): a preliminary report. Abstract. Proceedings of the American Society of Clinical Oncology 9: 22, 1990

    Google Scholar 

  • Peters WP, Shpall EJ, Jones RB, Olsen G, Bast RC, et al. Highdose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. Journal of Clinical Oncology 6: 1368–1375, 1988

    PubMed  CAS  Google Scholar 

  • Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. New England Journal of Medicine 316: 1493–1498, 1987

    Article  PubMed  CAS  Google Scholar 

  • Powles TJ, Smith IE, Ford HT, et al. Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet 1: 580–582, 1980

    Article  PubMed  CAS  Google Scholar 

  • Williams SF, Mick R, Dresser R, Golick J. Beschorner J, et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. Journal of Clinical Oncology 7: 1824–1830, 1989

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, Colorado, USA

    Roy B. Jones & Elizabeth J. Shpall

Authors
  1. Roy B. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth J. Shpall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, R.B., Shpall, E.J. Treatment of Breast Cancer in the 1990s. Drugs 43, 141–145 (1992). https://doi.org/10.2165/00003495-199243020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243020-00001

Keywords

Search

Navigation